Tested samples
Cell lines and IC
50
values (μM)
THP-1
HL60
Hep-G2
DU-145
MCF-7
3
74.76 ± 3.27
63.52 ± 5.2
90.99 ± 7.72
-
90.11 ± 7.26
5a
12.80 ± 1.34
23.52 ± 2.11
-
-
77.37 ± 7.12
5d
25.19 ± 1.94
20.81 ± 1.97
43.75 ± 3.42
83.73 ± 6.43
56.54 ± 3.78
5e
27.03 ± 2.03
28.70 ± 2.37
33.22 ± 3.07
37.70 ± 2.71
28.98 ± 1.91
5f
10.42 ± 0.68
13.50 ± 1.14
19.94 ± 2.15
12.23 ± 1.19
17.28 ± 2.02
5g
4.76 ± 0.51
7.90 ± 0.64
10.12 ± 0.88
5.21 ± 0.28
10.32 ± 0.86
5h
27.78 ± 3.04
37.59 ± 3.16
53.28 ± 5.32
36.48 ± 3.09
45.12 ± 3.27
Doxorubicin
1.44 ± 0.09
2.17 ± 0.26
4.31 ± 0.36
2.59 ± 0.20
6.00 ± 0.72
(-): > 100 μM
Table 1:
Cytotoxicity of the studied compounds towards cancer cell lines.